Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S100B | P04271 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 11/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 10/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 5/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.44 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | GFER | P55789 | 1/20 | 0.44 |
| ▸ | TERT | O14746 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 8/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.39 |
| ▸ | MAPT | P10636 | 7/20 | 0.39 |
| ▸ | HPGD | P15428 | 5/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10346490 | 0.83 | S100B (0.54) | S100BALDH1A1L3MBTL1MAPK1CYP3A4 | |
| SCHEMBL2430788 | 0.81 | ALDH1A1 (0.39) | ALDH1A1MAPK1CYP3A4TDP1TSHR | |
| SCHEMBL150568 | 0.81 | S100B (0.51) | S100BALDH1A1L3MBTL1MAPK1CYP3A4 | |
| SCHEMBL128645 | 0.77 | S100B (0.47) | S100BALDH1A1L3MBTL1MAPK1CYP3A4 | |
| SCHEMBL150569 | 0.76 | S100B (0.50) | S100BALDH1A1L3MBTL1MAPK1CYP3A4 | |
| SCHEMBL11431090 | 0.74 | S100B (0.70) | S100BALDH1A1L3MBTL1MAPK1CYP3A4 | |
| Sulfuric Acid SCHEMBL7955346 | 0.73 | S100B (0.80) | S100BALDH1A1L3MBTL1MAPK1CYP3A4 | |
| Methanesulfonamide SCHEMBL793229 | 0.73 | S100B (0.80) | S100BALDH1A1L3MBTL1MAPK1CYP3A4 | |
| SCHEMBL8235136 | 0.73 | S100B (0.63) | S100BALDH1A1L3MBTL1MAPK1CYP3A4 | |
| Sulfuric Acid SCHEMBL7111026 | 0.72 | S100B (0.42) | S100BALDH1A1L3MBTL1MAPK1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2547668-A1 | TOLUIDINE BLUE DERIVATIVES AS PHOTOSENSITISING COMPOUNDS | Pharmalucia Ltd (GB) | 2013-01-23 | — | — | EP | disclosed |
| US-20120328530-A1 | TOLUIDINE BLUE DERIVATIVES AS PHOTOSENSITISING COMPOUNDS | PHARMALUCIA LIMITED (GB) | 2012-12-27 | — | — | US | disclosed |
| WO-2011114137-A1 | TOLUIDINE BLUE DERIVATIVES AS PHOTOSENSITISING COMPOUNDS | PHARMALUCIA LIMITED (GB) | 2011-09-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120328530-A1 | TOLUIDINE BLUE DERIVATIVES AS PHOTOSENSITISING COMPOUNDS | TYR, TST, TH | S100B 1790/4885ALDH1A1 876/4885L3MBTL1 905/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.